EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A novel azithromycin resistance mutation in Mycoplasma genitalium induced in vitro

Teck-Phui Chua, Jennifer Danielewski, Catriona S Bradshaw, Dorothy A Machalek, Suzanne M Garland, Jose L Huaman, Jørgen S Jensen iD, Gerald L Murray iD

Journal of Antimicrobial Chemotherapy · 2025

DOI: 10.1093/jac/dkaf174 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2025. Verfasst von Teck-Phui Chua und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics, Gynaecology, and Newborn Health, University of Melbourne, Parkville, Victoria, Australia. Hauptthemen laut MEDLINE: Mycoplasma genitalium, Azithromycin, Anti-Bacterial Agents, Drug Resistance, Bacterial. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Australian Research Council Industrial Transformation Research Hub for Antimicrobial Resistance, NHMRC Investigator, Australian Government Research Training Program Scholarship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Mycoplasma genitalium is a sexually transmitted bacterium of increasing concern due to issues around antimicrobial resistance. Resistance is typically mediated by SNPs; however, the difficulty of isolation and culture of M. genitalium limits the ability to analyse the impact of individual mutations.

Objectives

The aim of this study was to generate and characterize antibiotic-resistant M. genitalium mutants in vitro to understand the development of macrolide resistance in this bacterium.

Methods

Sequential MIC assays for azithromycin were performed using the laboratory strain of M. genitalium (G37) grown in Hayflick medium. Bacteria were enumerated by droplet digital PCR (ddPCR) targeting mgpB, and a new ddPCR assay was established to detect specific mutations in the 23S rRNA gene. MICs of selected macrolide antibiotics were determined in Hayflick medium. Whole genome sequencing (WGS) was performed on the Oxford Nanopore MinION.

Results

After eight passages in azithromycin, a novel 23S rRNA gene mutation, G2057A (Escherichia coli numbering), was detected. The mutant did not display a detectable growth defect and had elevated MICs to azithromycin (8-fold), josamycin (8-fold) and erythromycin (16- to 32-fold). WGS did not identify other mutations likely to contribute to reduced macrolide susceptibility.

Conclusions

A novel 23S rRNA gene mutation was identified in M. genitalium. This variation is found in Mycoplasma hominis, which is intrinsically resistant to certain macrolides. While this mutation has not been observed clinically in M. genitalium, these findings have expanded our understanding of resistance mechanisms within the Mollicutes, in particular the propensity for M. genitalium to develop resistance, even in low concentrations of antibiotic, and the interaction of azithromycin with the ribosome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycoplasma genitaliumAzithromycinAnti-Bacterial AgentsDrug Resistance, BacterialMutationRNA, Ribosomal, 23SMicrobial Sensitivity TestsMacrolidesHumansWhole Genome SequencingMycoplasma Infections

Substanzen

AzithromycinAnti-Bacterial AgentsRNA, Ribosomal, 23SMacrolides

Autor:innen und Institutionen

  • Department of Obstetrics, Gynaecology, and Newborn Health, University of Melbourne, Parkville, Victoria, Australia.
  • Centre for Women's Infectious Diseases, The Royal Women's Hospital, Parkville, Victoria, Australia.
  • Molecular Microbiology Research Group, Murdoch Children's Research Institute, Parkville, Victoria, Australia.
  • Melbourne Sexual Health Centre, Alfred Health, Carlton, Victoria, Australia.
  • School of Translational Medicine, Monash University, Melbourne, Victoria, Australia.
  • Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Parkville, Victoria, Australia.

ORCID-Profile: Jørgen S Jensen, Gerald L Murray

Förderung

  • Australian Research Council Industrial Transformation Research Hub for Antimicrobial Resistance
  • NHMRC Investigator
  • Australian Government Research Training Program Scholarship

Zitieren

APA

Chua, T. P., Danielewski, J., Bradshaw, C. S., Machalek, D. A., Garland, S. M., Huaman, J. L., Jensen, J. S., & Murray, G. L. (2025). A novel azithromycin resistance mutation in Mycoplasma genitalium induced in vitro. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkaf174

Vancouver

Chua TP, Danielewski J, Bradshaw CS, Machalek DA, Garland SM, Huaman JL, et al. A novel azithromycin resistance mutation in Mycoplasma genitalium induced in vitro. Journal of Antimicrobial Chemotherapy. 2025. doi:10.1093/jac/dkaf174

BibTeX
@article{Chua2025,
  author = {Chua, Teck-Phui and Danielewski, Jennifer and Bradshaw, Catriona S and Machalek, Dorothy A and Garland, Suzanne M and Huaman, Jose L and Jensen, Jørgen S and Murray, Gerald L},
  title = {A novel azithromycin resistance mutation in Mycoplasma genitalium induced in vitro},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2025},
  doi = {10.1093/jac/dkaf174}
}
Kostenlos starten →